Multicenter Orthopaedics Outcomes Network for ACL Reconstructions

StatusActive, Not Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv20
  2. Notable Primary completion date: Dec 2026 to Dec 2027
    • Study completion date: Dec 2027 to Dec 2028
    v19
  3. Notable Primary completion date: May 2021 to Dec 2026v18 Show 5 more changesShow less
    • Trial status: Completed to Active, Not Recruiting
    • Study completion date: Dec 2021 to Dec 2027
    • Eligibility criteria shortened, about 36 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Study description revised
  4. Re-verified, no change to tracked fieldsv17
  5. Minor Study sites revised (8)v16
Show 14 earlier versionsHide 14 earlier versions
  1. Minor Trial status: Active, Not Recruiting to Completed
    • Enrollment target: estimated 5000 to confirmed 3294
    • Primary completion date changed from estimate of Dec 2023 to May 2021
    • Study completion date changed from estimate of Dec 2024 to Dec 2021
    v15
  2. 2 versions Re-verified since Apr 23, 2020, no change to tracked fieldsv13-v14
  3. Minor Study sites: 10 to 8v12
  4. Notable Lead sponsor: Vanderbilt University to Vanderbilt University Medical Center
    • Study sites: 9 to 10
    v11
  5. Notable Primary completion date: Dec 2016 to Dec 2023
    • Study completion date: Dec 2017 to Dec 2024
    • Start date: Jan 2007 to Jan 2002
    v10
  6. Minor Study description expanded, about 3 wordsv9
  7. Minor Trial status: Enrolling by Invitation to Active, Not Recruitingv8
  8. Minor Primary completion date: Dec 2016
    • Study completion date: Dec 2016 to Dec 2017
    • Study description expanded, about 4 words
    v7
  9. Minor Eligibility criteria expanded, about 21 wordsv6
  10. Minor Collaborators: 1 to 2v5
  11. Minor Eligibility criteria shortened, about 14 wordsv4
  12. Minor Eligibility criteria shortened, about 9 words
    • Study title shortened, about 1 word
    v3
  13. Minor Trial status: Recruiting to Enrolling by Invitation
    • Site details revised at 9 of 9 sites
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to determine the effect of modifiable risk factors on knee function, osteoarthritis, and re-rupture of the anterior cruciate ligament (ACL) following ACL reconstruction.
Trial Details
NCT Number NCT00463099
Lead Sponsor Vanderbilt University Medical Center
Collaborators: National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Conditions
(from sponsor)
Rupture of Anterior Cruciate Ligament
Related terms Anterior Cruciate Ligament Injuries, Knee Injuries
Enrollment 3,294 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov